MACLEAN ALEXANDRA (Chief Executive Officer) received a stock award from AVENUE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/25/2024ACC: 0001104659-24-102836
Officer· Chief Executive Officer
Since Aug 2022
+170K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
170K acquired
Non-Derivative Transactions1
COMMON STOCK, PAR VALUE $0.0001
Direct
Shares
+170K
Price / share
—
Trade value
—
% of position
New position
9/23/2024
0.00→170K
Total
Net shares
+170K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK, PAR VALUE $0.0001 Direct | 9/23/2024 | A · Award | +170K | — | — | New position | 0.00 | 170K |
| Total | +170K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported